Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01671592 · ClinicalTrials.gov registry record · Phase 1
Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)
A Phase 1 study, sponsored by Pawel Kalinski.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01671592: Completed Phase 1 study, sponsored by Pawel Kalinski.
NCT01671592 is a Phase 1 study that has completed, run by Pawel Kalinski. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01671592, a Phase 1 study, has completed, sponsored by Pawel Kalinski.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study will evaluate the safety and feasibility MRI tracking of a vaccine produced from a persons cancer cells injected intradermally once a day for 3 consecutive days. One of the daily doses will contain a chemical that can be detected by an MRI. That will be either the 1st or 3rd day of the 3 day course. On that day MRI scans will be performed 6 and 24 hours after the injection on that day. Patients may be able to receive booster doses every 1-2 months
Interventions
- BIOLOGICAL DC Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
What the finished NCT01671592 record still lists
NCT01671592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which DC Vaccine is the first listed.
NCT01671592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01671592 about?
NCT01671592 is a clinical study titled "Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)". This study will evaluate the safety and feasibility MRI tracking of a vaccine produced from a persons cancer cells injected intradermally once a day for 3 consecutive days. One of the daily doses will contain a chemical that can be detected by an MRI. That will be either the 1st or 3rd day of the 3 ...
What is the current status of trial NCT01671592?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2013-01. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01671592?
The interventions under investigation include: DC Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01671592?
This trial is sponsored by Pawel Kalinski, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01671592's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia